Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT06337331
Title Adding Venetoclax to the High-dose Chemotherapy Regimen Prior to Mismatche Allogeneic Stem Cell Transplant
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements No
Sponsors Northside Hospital, Inc.
Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.